1. Home
  2. ASPN vs KALV Comparison

ASPN vs KALV Comparison

Compare ASPN & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • KALV
  • Stock Information
  • Founded
  • ASPN 2001
  • KALV N/A
  • Country
  • ASPN United States
  • KALV United States
  • Employees
  • ASPN N/A
  • KALV N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPN Consumer Discretionary
  • KALV Health Care
  • Exchange
  • ASPN Nasdaq
  • KALV Nasdaq
  • Market Cap
  • ASPN 573.2M
  • KALV 551.2M
  • IPO Year
  • ASPN 2014
  • KALV N/A
  • Fundamental
  • Price
  • ASPN $3.15
  • KALV $13.41
  • Analyst Decision
  • ASPN Buy
  • KALV Strong Buy
  • Analyst Count
  • ASPN 6
  • KALV 8
  • Target Price
  • ASPN $13.00
  • KALV $26.43
  • AVG Volume (30 Days)
  • ASPN 3.5M
  • KALV 1.4M
  • Earning Date
  • ASPN 11-06-2025
  • KALV 11-10-2025
  • Dividend Yield
  • ASPN N/A
  • KALV N/A
  • EPS Growth
  • ASPN N/A
  • KALV N/A
  • EPS
  • ASPN N/A
  • KALV N/A
  • Revenue
  • ASPN $352,852,000.00
  • KALV $1,426,000.00
  • Revenue This Year
  • ASPN N/A
  • KALV N/A
  • Revenue Next Year
  • ASPN $8.56
  • KALV $234.65
  • P/E Ratio
  • ASPN N/A
  • KALV N/A
  • Revenue Growth
  • ASPN N/A
  • KALV N/A
  • 52 Week Low
  • ASPN $2.92
  • KALV $7.30
  • 52 Week High
  • ASPN $15.38
  • KALV $17.28
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 25.11
  • KALV 57.38
  • Support Level
  • ASPN $2.98
  • KALV $10.55
  • Resistance Level
  • ASPN $3.20
  • KALV $14.97
  • Average True Range (ATR)
  • ASPN 0.34
  • KALV 0.87
  • MACD
  • ASPN -0.16
  • KALV 0.22
  • Stochastic Oscillator
  • ASPN 3.86
  • KALV 60.75

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: